Loading…
McKesson Corporation is projected to rise to $893.07 by 2027, a +11% move from its current price of $805.96. MCK is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $794.40 | $806.15 | $818.08 | +0.02% |
| Jul 14 | $789.77 | $806.34 | $823.27 | +0.05% |
| Jul 15 | $786.27 | $806.54 | $827.32 | +0.07% |
| Jul 16 | $783.37 | $806.73 | $830.78 | +0.10% |
| Jul 17 | $780.85 | $806.92 | $833.87 | +0.12% |
| Jul 18 | $778.59 | $807.11 | $836.69 | +0.14% |
| Jul 19 | $776.53 | $807.31 | $839.30 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $776.53 | $807.31 | $839.30 | +0.17% |
| Week 2 | $765.41 | $808.66 | $854.35 | +0.33% |
| Week 3 | $757.27 | $810.01 | $866.41 | +0.50% |
| Week 4 | $750.68 | $811.36 | $876.95 | +0.67% |
| Week 5 | $745.07 | $812.72 | $886.51 | +0.84% |
| Week 6 | $740.15 | $814.08 | $895.39 | +1.01% |
| Week 7 | $735.75 | $815.44 | $903.75 | +1.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.
It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers.
McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
McKesson Corporation (MCK) is currently trading at $807.33 per share. It has a market capitalization of $94.52B and is ranked 168. The 30-day price action spans from $737.35 to $883.95, reflecting recent activity within a broader technical context.
Technical indicators show a bullish tilt with RSI(14) at 60, while the stock sits near the $807.33 resistance and $734.82 support levels. The 50-day simple moving average sits at $770.61 and the 200-day simple moving average at $827.96, framing a near-term range around the current price. Annualized volatility is around 30%, underscoring notable price movement potential over time.
A major floor 12.8% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
Price is pressing into resistance (1.6% away) — a breakout level to watch.
A major ceiling 23.5% above — clearing it would confirm fresh momentum.
Key MCK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $801.80 | Buy | $798.81 | Buy |
| MA 10 | $783.00 | Buy | $789.53 | Buy |
| MA 20 | $776.80 | Buy | $780.79 | Buy |
| MA 50 | $769.13 | Buy | $786.51 | Buy |
| MA 100 | $835.14 | Sell | $804.89 | Buy |
| MA 200 | $829.62 | Sell | $800.16 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.86 | Neutral |
| Stoch RSI (14) | 74.06 | Neutral |
| CCI (20) | 116.59 | Buy |
| Williams %R (14) | -17.21 | Info |
| MACD (12,26,9) | 5.42 | Buy |
| ROC (12) | 5.50 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 82.79 | Sell |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 32.27 | Buy |
| Ultimate (7,14,28) | 70.01 | Sell |
| Momentum (10) | 42.15 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 815.66 | Sell |
| ADX (14) | 15.81 | Neutral |
| ATR (14) | 11.60 | Info |
The 30-day technical picture is trending bullish, with a positive tilt in momentum and a constructive setup near key levels. The RSI at 60 suggests room to move higher without being overbought, and the price action remains within a defined channel around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $725.17 | $805.96 | $1,039.32 | 0% | Neutral | |
| $731.45 | $893.07 | $1,140.03 | +11% | Neutral | |
| $757.12 | $941.79 | $1,234.75 | +17% | Neutral | |
| $819.18 | $1,034.72 | $1,385.47 | +28% | Bullish | |
| $883.48 | $1,131.01 | $1,541.69 | +40% | Bullish | |
| $1,030.86 | $1,335.81 | $1,849.62 | +66% | Bullish | |
| $1,132.67 | $1,484.31 | $2,084.49 | +84% | Bullish | |
| $1,175.08 | $1,556.11 | $2,213.61 | +93% | Bullish | |
| $1,274.19 | $1,704.14 | $2,453.17 | +111% | Bullish | |
| $1,259.85 | $1,700.91 | $2,475.78 | +111% | Bullish | |
| $1,887.98 | $2,658.54 | $4,055.22 | +230% | Bullish | |
| $3,016.55 | $4,555.67 | $7,448.86 | +465% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $725.17 | $805.96 | $969.78 | +0.00% |
| August 2026 | $703.28 | $823.18 | $984.35 | +2.14% |
| September 2026 | $700.34 | $823.69 | $992.67 | +0.06% |
| October 2026 | $717.38 | $847.20 | $1,027.76 | +2.85% |
| November 2026 | $726.71 | $861.21 | $1,050.52 | +1.65% |
| December 2026 | $713.01 | $847.70 | $1,039.32 | -1.57% |
Click any year to see its month-by-month MCK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MCK to range from $725.17 to $1,039.32 through 2026. The $805.96 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MCK price prediction for 2027 points to an average of $893.07 (low $731.45, high $1,140.03) — a potential gain of +11% on today's $805.96. A consolidation phase looks the most probable path here.
In 2028, MCK is projected to trade between $757.12 and $1,234.75, averaging $941.79 — a potential gain of +17% from today's $805.96. That is up +5% on the projected 2027 average. Price action looks broadly range-bound.
McKesson Corporation's 2029 outlook centres on $1,034.72, within a $819.18 to $1,385.47 range. That is up +10% on the projected 2028 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, MCK could reach as high as $1,541.69, with a base case around $1,131.01 and support toward $883.48 — roughly +40% from $805.96. Momentum favours further upside here.
Expect MCK to range from $1,030.86 to $1,849.62 through 2031. The $1,335.81 average target implies a +66% move from current prices. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The MCK price prediction for 2032 points to an average of $1,484.31 (low $1,132.67, high $2,084.49) — a potential gain of +84% on today's $805.96. Momentum favours further upside here.
In 2033, MCK is projected to trade between $1,175.08 and $2,213.61, averaging $1,556.11 — a potential gain of +93% from today's $805.96. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
McKesson Corporation's 2034 outlook centres on $1,704.14, within a $1,274.19 to $2,453.17 range. That is up +10% on the projected 2033 average. That marks a +111% change versus current levels. Momentum favours further upside here.
By 2035, MCK could reach as high as $2,475.78, with a base case around $1,700.91 and support toward $1,259.85 — roughly +111% from $805.96. Buyers look set to stay in control over this stretch.
Expect MCK to range from $1,887.98 to $4,055.22 through 2040. The $2,658.54 average target implies a +230% move from current prices. That is up +56% on the projected 2035 average. Momentum favours further upside here.
The MCK price prediction for 2050 points to an average of $4,555.67 (low $3,016.55, high $7,448.86) — a potential gain of +465% on today's $805.96. Buyers look set to stay in control over this stretch.
Investing $1,000 in MCK today (≈ 1.240756 MCK) could be worth
$5,652.47
+$4,652.47 (+465%) by 2050 · US Dollar
Based on the average projected MCK price of $4,555.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCKwould be worth at today's price.
$1,000 invested in MCK on Jul 10, 2025 (≈ 1.399502 MCK) would be worth
$1,127.94
+$127.94 (+12.8%) today · 1.13× · US Dollar
Based on a MCK entry price of $714.54 vs. today's $805.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $786.3 | $1,025 | +2.5% |
| 1 month ago | $790.44 | $1,019.63 | +2.0% |
| 3 months ago | $865.6 | $931.1 | -6.9% |
| 6 months ago | $825.62 | $976.19 | -2.4% |
| 1 year ago | $714.54 | $1,127.94 | +12.8% |
| All time (5.0y) ago | $189.32 | $4,257.13 | +325.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCK forecast.
Our base-case forecast reaches $1,600.00 around 2034.
Implied market cap at $1,600.00: $187.32B
The multi-year forecast points to a sustained upside path. In 2026 the average price is $807.33 (min $725.17, max $1,041.40) with neutral sentiment and 0% ROI, followed by growth into 2027 (avg $903.06, min $739.45, max $1,153.16; ROI 11.9%; sentiment Neutral) and 2028 (avg $952.85, min $765.87, max $1,249.56; ROI 18%; sentiment Neutral). The trajectory strengthens into 2029 (avg $1,050.50; max $1,406.90; ROI 30.1%; sentiment Bullish) and 2030 (avg $1,160.15; max $1,581.70; ROI 43.7%; sentiment Bullish).
Beyond, 2031 shows an avg of $1,366.81 (ROI 69.3%), 2032 $1,520.73 (ROI 88.4%), 2033 $1,604.56 (ROI 98.8%), 2034 $1,750.11 (ROI 116.8%), and 2035 $1,749.51 (ROI 116.7%) with bullish sentiment. The forecast accelerates further to 2040 (avg $2,758.18; max $4,207.60; ROI 241.6%; sentiment Bullish) and culminates in 2050 (avg $4,754.71; max $7,774.82; ROI 488.9%; sentiment Bullish). These figures depict a clear long-term rally, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast gives an average price of $1,160.15 with a min of $906.12 and a max of $1,581.70; ROI 43.7%; sentiment BULLISH.
The long-term outlook is bullish, with rising average prices and ROI reaching 43.7% in 2030 and up to 488.9% by 2050; however, these are estimates and not guarantees.
Yes. The forecast shows potential for prices above $2,000, with the 2032 max at $2,135.95 and the 2033 max at $2,282.84.
Current price: $807.33. Market cap: $94.52B.
Near-term indicators show bullish sentiment with RSI(14) at 60, 50-day SMA at $770.61, 200-day SMA at $827.96, support at $734.82, resistance at $807.33, and a 30-day range of $737.35 to $883.95.
McKesson Corporation Community Discussion
0Share your McKesson Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.